GE vs XERS · P/E 44, rev $13.35B vs rev $175.2M
GE Aerospace (GE) versus Xeris Pharmaceuticals Inc (XERS) — a side-by-side from cached financials, not a winner call.
GE Aerospace (GE) is a aerospace & defense company listed on NYSE.
Xeris Pharmaceuticals Inc (XERS) is a biotechnology company listed on US.
Latest reported GE revenue for 2026-06-30 was $13.35B. Net income was $2.37B. Revenue was up 7.7% from 2026-03-31 to 2026-06-30. GE currently screens at market cap $373.04B and trailing P/E 44.4.
Latest reported XERS revenue for 2026-06-30 was $175.2M. Net income was -$28.9M. XERS currently screens at market cap $760.7M.
GE currently screens at market cap $373.04B and trailing P/E 44.4. XERS currently screens at market cap $760.7M.
Not investment advice. Open the GE and XERS stock pages for the full models.
Not investment advice.